Form POS AM iSpecimen Inc.
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Post-Effective Amendment No. 1 to the Registration Statement (No. 333-261640) on Form S-1 of iSpecimen Inc. of our report dated March 22, 2022 relating to the financial statements of iSpecimen Inc., as of December 31, 2021 and 2020, appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference to our firm under the heading "Experts" in such Prospectus.
/s/ Wolf & Company, P.C.
Boston, Massachusetts
May 26, 2022
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toronto Stock Exchange, Alithya Group Inc., The View From The C-Suite
- Ridgeline Minerals Announces Upsized Non-Brokered Private Placement to $2.2M
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!